Editor's Choice

Stay up to date with the latest updates from the global pharmaceuticals industry.

Latest Update

Half of patients have suboptimal response to statins
20 April, 2019
Over half of patients who are prescribed statins do not see their...
> read more

Editor's Choice

New laws in China to ensure steady drug supply
Thursday, April 18, 2019 by China’s National Health Commission (NHC) has stated that it will monitor the country’s drugs market more closely in order to ensure a sufficient supply of essential medicines.

Biotechpharma to Expand Process Development and GMP Manufacturing Capacity to 5,000 L
Thursday, April 18, 2019 by Biotechpharma UAB will expand its existing manufacturing facility by adding a new line of bioreactors

Underwater forests a treasure trove of new drugs
Wednesday, April 10, 2019 by In light of the increasing resistant microbes, researchers are taking their search for drug candidates offshore. A new study published in Frontiers in Microbiology reported that a...

Epilepsy Society calls for review of UK supply chain after increase in access issues
Wednesday, April 10, 2019 by The Epilepsy Society has recently spoken out about the “steep rise” in UK patients experiencing difficulty in accessing seizure medication.

Call for temporary medicines export ban in light of no-deal Brexit outcome
Tuesday, April 02, 2019 by The UK pharma industry has called for a temporary medicines export ban to prevent the NHS from being hit by national drugs shortage in the event of no-deal Brexit.

NHS England’s medicines chief calls for faster market access
Tuesday, April 02, 2019 by NHS England now plays a key gatekeeper role for the industry’s high cost specialised medicines, and has become increasingly commercially savvy over recent years, working alongside...

SHL makes debut at APLAR-ARA 2019
Friday, March 15, 2019 by SHL Group will make its first appearance at the 21st Asia Pacific League of Associations for Rheumatology Congress from 8-11 April in Brisbane, Australia. The congress will be held...

UCSF discover potential new treatment approach for type 1 diabetes
Tuesday, February 26, 2019 by Researchers at the University of California, San Francisco (UCSF) Diabetes Centre have uncovered evidence to suggest assumptions about the cause of type 1 diabetes are incorrect,...

Greater Manchester backs move to outcome-based payment
Monday, February 25, 2019 by The trend towards paying for medicines based on patient outcomes (OBP) are growing in both the US and Europe

Novel immunotherapy for lung cancer
Tuesday, February 19, 2019 by Researchers at the University of Louisville have been testing a protein-based molecule they originally developed to boost T cells as a cancer treatment. Whilst testing the...

FDA funding set to jump after Congress votes to avert shutdown
Monday, February 18, 2019 by Congress has just approved a budget deal to avert another government shutdown

Anton Paar Research Prize has been awarded
Monday, February 18, 2019 by The first Anton Paar Research Award for Instrumental Analysis and Characterization goes to research teams from Finland and Austria.

Europe’s medicines tracking system goes live
Wednesday, February 13, 2019 by A new world-first, digital tracking system covering the medicines supply chain across the EU has gone live, promising greater security against counterfeit medicines.

FDA to crack down on dietary supplements
Wednesday, February 13, 2019 by The FDA is cracking down on those selling dietary supplement and has sent warning letters to companies who claim, without scientific evidence, that their products can cure diseases...

The childproof pack with ultimate user-friendliness
Tuesday, February 12, 2019 by Together with the French company ACD, Rondo AG is developing new handy packaging called Securp'ak

The Falsified Medicines Directive comes into action tomorrow
Friday, February 08, 2019 by The Falsified Medicines Directive (FMD) is a new EU initiative which comes to force tomorrow, which aims to protect patients from counterfeit medicines.

Parallel Trade Conference
Friday, February 08, 2019 by SMi presented its 13th annual Parallel Trade conference, which took place in London on the 5-6 of February 2019.

Brexit could hinder CAR-T reimbursement in Europe
Friday, February 01, 2019 by The UK NHS, NICE and the government have joined forces to make CAR-T therapies available to patients, working closely with manufacturers of approved therapies, Gilead and Novartis

UK Pharma Warns that skills shortage and Brexit will hit R&D
Friday, February 01, 2019 by The Association of the British Pharmaceutical Industry (ABPI) has warned that the UK is in danger of losing its world-leading research and development status

Editor's Choice Archive

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.